30 Oct 2026

HM Revenue & Customs (HMRC) has confirmed the scope of a new zero rate of VAT for medicines provided free of charge, removing a tax cost from qualifying early-access, trial and post-trial treatment arrangements. The measure was detailed alongside the Budget on 28 October.

Previously, medicines given away by manufacturers could be treated as taxable supplies even where patients or the NHS paid nothing. The standard 20% VAT charge could therefore arise on the value of medicines donated through some access programmes.

The new relief covers licensed and unlicensed medicines donated for NHS-funded treatment, medicines supplied through the Early Access to Medicines Scheme, products used in clinical trials and continued treatment for trial participants. Qualifying supplies made through intermediaries and imports are also included. Clinical-trial and post-trial donations do not have to take place within the NHS.

The measure is intended to apply to eligible supplies from 23 June 2026, but the primary legislation is still to be enacted in Finance Bill 2026–27. Pending Royal Assent, HMRC will not seek output VAT on qualifying supplies made from that date and will consider corrections where VAT has already been accounted for.

Suppliers must obtain and retain certification from recipients confirming that the medicine is used for an eligible purpose. Trial medicines donated before 23 June may continue to be treated as samples where the relevant conditions are met.

The change reduces the effective cost of maintaining free treatment access without altering medicine licensing, NHS reimbursement eligibility or the clinical requirements of individual programmes.

Source: HM Revenue & Customs
Link: VAT zero rate on donated medicines
Date: 28 October 2026

Source: HM Revenue & Customs
Link: Revenue and Customs Brief 12 (2026): VAT zero rate on donated medicines
Date: 28 October 2026